[
  {
    "publication_date": "2026-06-20",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Curt Mikael von Euler-Chelpin",
    "person_in_leading_position": "Curt Mikael von Euler-Chelpin",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-18",
    "volume": 3000.0,
    "volume_raw": "3000,0",
    "volume_unit": "Antal",
    "price": 16.1,
    "price_raw": "16,10",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 48300.00000000001,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-15",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Blake Leitch",
    "person_in_leading_position": "Blake Leitch",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "Ja",
    "correction_description": "change from allotment to acquisition",
    "first_report": "",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-15",
    "volume": 5061.0,
    "volume_raw": "5061,0",
    "volume_unit": "Antal",
    "price": 15.14079,
    "price_raw": "15,14079",
    "currency": "SEK",
    "trading_venue": "UBS TRADING",
    "transaction_value": 76627.53819,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-15",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Blake Leitch",
    "person_in_leading_position": "Blake Leitch",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-15",
    "volume": 5061.0,
    "volume_raw": "5061,0",
    "volume_unit": "Antal",
    "price": 15.14079,
    "price_raw": "15,14079",
    "currency": "SEK",
    "trading_venue": "UBS TRADING",
    "transaction_value": 76627.53819,
    "status": "Reviderad",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-15",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Blake Leitch",
    "person_in_leading_position": "Blake Leitch",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "Ja",
    "correction_description": "change from allotment to acquisition",
    "first_report": "",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-12",
    "volume": 44939.0,
    "volume_raw": "44939,0",
    "volume_unit": "Antal",
    "price": 14.797319,
    "price_raw": "14,797319",
    "currency": "SEK",
    "trading_venue": "UBS TRADING",
    "transaction_value": 664976.718541,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-15",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Blake Leitch",
    "person_in_leading_position": "Blake Leitch",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-12",
    "volume": 44939.0,
    "volume_raw": "44939,0",
    "volume_unit": "Antal",
    "price": 14.797319,
    "price_raw": "14,797319",
    "currency": "SEK",
    "trading_venue": "UBS TRADING",
    "transaction_value": 664976.718541,
    "status": "Reviderad",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-12",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Bladh",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-12",
    "volume": 2010.0,
    "volume_raw": "2010,0",
    "volume_unit": "Antal",
    "price": 14.86,
    "price_raw": "14,86",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 29868.6,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-05",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "Ja",
    "correction_description": "Berörde ej Ribbskottet utan familjemedlem",
    "first_report": "",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-03",
    "volume": 19999.0,
    "volume_raw": "19999,0",
    "volume_unit": "Antal",
    "price": 24.6,
    "price_raw": "24,6",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 491975.4,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-05",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-03",
    "volume": 19999.0,
    "volume_raw": "19999,0",
    "volume_unit": "Antal",
    "price": 24.6,
    "price_raw": "24,6",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 491975.4,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-05",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh, Ribbskottet",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-03",
    "volume": 19999.0,
    "volume_raw": "19999,0",
    "volume_unit": "Antal",
    "price": 24.6,
    "price_raw": "24,6",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 491975.4,
    "status": "Reviderad",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-05",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Bladh",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-03",
    "volume": 26620.0,
    "volume_raw": "26620,0",
    "volume_unit": "Antal",
    "price": 24.6,
    "price_raw": "24,6",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 654852.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-06-05",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Bladh",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2026-06-03",
    "volume": 26620.0,
    "volume_raw": "26620,0",
    "volume_unit": "Antal",
    "price": 24.6,
    "price_raw": "24,6",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 654852.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-05-04",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh, Ribbskottet",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSpray Pharma AB BTA",
    "isin": "SE0028355099",
    "transaction_date": "2026-05-04",
    "volume": 16594.0,
    "volume_raw": "16594,0",
    "volume_unit": "Antal",
    "price": 26.49,
    "price_raw": "26,49",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 439575.06,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-04-22",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Ekblom",
    "person_in_leading_position": "Anders Ekblom",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSPRAY BTA",
    "isin": "SE0028355099",
    "transaction_date": "2026-04-21",
    "volume": 6050.0,
    "volume_raw": "6050,0",
    "volume_unit": "Antal",
    "price": 20.0,
    "price_raw": "20,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 121000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-04-22",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Christine Lind",
    "person_in_leading_position": "Christine Lind",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Xspray Pharma AB BTA",
    "isin": "SE0028355099",
    "transaction_date": "2026-04-21",
    "volume": 810.0,
    "volume_raw": "810,0",
    "volume_unit": "Antal",
    "price": 20.0,
    "price_raw": "20,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 16200.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-04-22",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Christine Lind",
    "person_in_leading_position": "Christine Lind",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Lösen minskning",
    "category": "other",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "Xspray Pharma AB teckningsrätter",
    "isin": "SE0028355081",
    "transaction_date": "2026-04-21",
    "volume": 8100.0,
    "volume_raw": "8100,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-04-22",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh, Ribbskottet",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSPRAY BTA",
    "isin": "SE0028355099",
    "transaction_date": "2026-04-21",
    "volume": 475764.0,
    "volume_raw": "475764,0",
    "volume_unit": "Antal",
    "price": 20.0,
    "price_raw": "20,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 9515280.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-04-22",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh, Ribbskottet",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSPRAY BTA",
    "isin": "SE0028355099",
    "transaction_date": "2026-04-21",
    "volume": 1818.0,
    "volume_raw": "1818,0",
    "volume_unit": "Antal",
    "price": 20.0,
    "price_raw": "20,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 36360.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-04-22",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Bladh",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSPRAY BTA",
    "isin": "SE0028355099",
    "transaction_date": "2026-04-21",
    "volume": 30420.0,
    "volume_raw": "30420,0",
    "volume_unit": "Antal",
    "price": 20.0,
    "price_raw": "20,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 608400.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-04-22",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Cecilia Stureborg von Schéele",
    "person_in_leading_position": "Anders Ekblom",
    "position": "Styrelseordförande",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Lösen minskning",
    "category": "other",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "Teckningsrätt",
    "isin": "SE0028355081",
    "transaction_date": "2026-04-21",
    "volume": 7336180.0,
    "volume_raw": "7336180,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-04-22",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Cecilia Stureborg von Schéele",
    "person_in_leading_position": "Anders Ekblom",
    "position": "Styrelseordförande",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "BTA (betald tecknad aktie)",
    "isin": "SE0028355099",
    "transaction_date": "2026-04-21",
    "volume": 733618.0,
    "volume_raw": "733618,0",
    "volume_unit": "Antal",
    "price": 20.0,
    "price_raw": "20,00",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 14672360.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-04-22",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Christine Lind",
    "person_in_leading_position": "Christine Lind",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "Xspray Pharma AB teckningsrätter",
    "isin": "SE0028355081",
    "transaction_date": "2026-04-17",
    "volume": 4.0,
    "volume_raw": "4,0",
    "volume_unit": "Antal",
    "price": 0.6773,
    "price_raw": "0,6773",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 2.7092,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-19",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Bladh",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Xspray BTA",
    "isin": "SE0026140865",
    "transaction_date": "2025-09-19",
    "volume": 2063.0,
    "volume_raw": "2063,0",
    "volume_unit": "Antal",
    "price": 52.31,
    "price_raw": "52,31",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 107915.53,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-15",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Bladh, Ribbskottet",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Xspray BTA",
    "isin": "SE0026140865",
    "transaction_date": "2025-09-15",
    "volume": 3821.0,
    "volume_raw": "3821,0",
    "volume_unit": "Antal",
    "price": 48.4,
    "price_raw": "48,4",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 184936.4,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-12",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh, Ribbskottet",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "Ja",
    "correction_description": "Ändrat datum",
    "first_report": "",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Xspray BTA",
    "isin": "SE0026140865",
    "transaction_date": "2025-09-12",
    "volume": 23821.0,
    "volume_raw": "23821,0",
    "volume_unit": "Antal",
    "price": 35.0,
    "price_raw": "35,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 833735.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-12",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Christine Lind",
    "person_in_leading_position": "Christine Lind",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSpray Pharma AB BTU",
    "isin": "SE0026140865",
    "transaction_date": "2025-09-09",
    "volume": 550.0,
    "volume_raw": "550,0",
    "volume_unit": "Antal",
    "price": 35.0,
    "price_raw": "35,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 19250.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-12",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Christine Lind",
    "person_in_leading_position": "Christine Lind",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSpray Pharma AB BTU",
    "isin": "SE0026140865",
    "transaction_date": "2025-09-09",
    "volume": 186.0,
    "volume_raw": "186,0",
    "volume_unit": "Antal",
    "price": 35.0,
    "price_raw": "35,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 6510.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-12",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Bladh",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Xspray BTA",
    "isin": "SE0026140865",
    "transaction_date": "2025-09-09",
    "volume": 27467.0,
    "volume_raw": "27467,0",
    "volume_unit": "Antal",
    "price": 35.0,
    "price_raw": "35,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 961345.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-12",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Xspray BTA",
    "isin": "SE0026140865",
    "transaction_date": "2025-09-09",
    "volume": 1652.0,
    "volume_raw": "1652,0",
    "volume_unit": "Antal",
    "price": 35.0,
    "price_raw": "35,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 57820.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-12",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh, Ribbskottet",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Xspray BTA",
    "isin": "SE0026140865",
    "transaction_date": "2025-09-09",
    "volume": 23821.0,
    "volume_raw": "23821,0",
    "volume_unit": "Antal",
    "price": 35.0,
    "price_raw": "35,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 833735.0,
    "status": "Reviderad",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-12",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh, Ribbskottet",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "Xspray BTA",
    "isin": "SE0026140865",
    "transaction_date": "2025-09-09",
    "volume": 430000.0,
    "volume_raw": "430000,0",
    "volume_unit": "Antal",
    "price": 35.0,
    "price_raw": "35,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 15050000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-10",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Ekblom",
    "person_in_leading_position": "Anders Ekblom",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTU (betald tecknad unit)",
    "instrument_name": "XSpray Pharma AB BTU",
    "isin": "SE0026140857",
    "transaction_date": "2025-09-09",
    "volume": 500.0,
    "volume_raw": "500,0",
    "volume_unit": "Antal",
    "price": 35.0,
    "price_raw": "35,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 17500.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-09",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Flerie Invest AB",
    "person_in_leading_position": "Anders Ekblom",
    "position": "Styrelseordförande",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Lösen minskning",
    "category": "other",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "Teckningsrätt",
    "isin": "SE0026140857",
    "transaction_date": "2025-09-09",
    "volume": 6669260.0,
    "volume_raw": "6669260,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-09-09",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Flerie Invest AB",
    "person_in_leading_position": "Anders Ekblom",
    "position": "Styrelseordförande",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "BTA (betald tecknad aktie)",
    "isin": "SE0026140865",
    "transaction_date": "2025-09-09",
    "volume": 666926.0,
    "volume_raw": "666926,0",
    "volume_unit": "Antal",
    "price": 35.0,
    "price_raw": "35,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 23342410.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-01-13",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Flerie Invest AB",
    "person_in_leading_position": "Anders Ekblom",
    "position": "Styrelseordförande",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "Aktie",
    "isin": "SE0009973563",
    "transaction_date": "2025-01-10",
    "volume": 168000.0,
    "volume_raw": "168000,0",
    "volume_unit": "Antal",
    "price": 29.75,
    "price_raw": "29,75",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 4998000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-12-20",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Christine Lind",
    "person_in_leading_position": "Christine Lind",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Tilldelning",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "XSpray Pharma AB",
    "isin": "SE0009973563",
    "transaction_date": "2024-12-18",
    "volume": 38.0,
    "volume_raw": "38,0",
    "volume_unit": "Antal",
    "price": 40.0,
    "price_raw": "40,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 1520.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-12-02",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Christine Lind",
    "person_in_leading_position": "Christine Lind",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSPRAY BTA",
    "isin": "SE0023312764",
    "transaction_date": "2024-11-29",
    "volume": 666.0,
    "volume_raw": "666,0",
    "volume_unit": "Antal",
    "price": 40.0,
    "price_raw": "40,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 26640.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-12-02",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Ekblom",
    "person_in_leading_position": "Anders Ekblom",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSPRAY BTA",
    "isin": "SE0023312764",
    "transaction_date": "2024-11-29",
    "volume": 500.0,
    "volume_raw": "500,0",
    "volume_unit": "Antal",
    "price": 40.0,
    "price_raw": "40,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 20000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-12-02",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Flerie Invest AB",
    "person_in_leading_position": "Anders Ekblom",
    "position": "Styrelseordförande",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "BTA Xspray Pharma AB",
    "isin": "SE0023312764",
    "transaction_date": "2024-11-29",
    "volume": 591023.0,
    "volume_raw": "591023,0",
    "volume_unit": "Antal",
    "price": 40.0,
    "price_raw": "40,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 23640920.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-12-02",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Flerie Invest AB",
    "person_in_leading_position": "Anders Ekblom",
    "position": "Styrelseordförande",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Lösen minskning",
    "category": "other",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "TR Xspray Pharma AB",
    "isin": "SE0023312756",
    "transaction_date": "2024-11-29",
    "volume": 5910238.0,
    "volume_raw": "5910238,0",
    "volume_unit": "Antal",
    "price": 0.0,
    "price_raw": "0,0",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 0.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-12-02",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "IARU Institutet för Affärsjuridisk Rådgivning i Uppsala AB",
    "person_in_leading_position": "Torbjörn Koivisto",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSPRAY BTA",
    "isin": "SE0023312764",
    "transaction_date": "2024-11-29",
    "volume": 1500.0,
    "volume_raw": "1500,0",
    "volume_unit": "Antal",
    "price": 40.0,
    "price_raw": "40,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 60000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-11-30",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Maris Hartmanis",
    "person_in_leading_position": "Maris Hartmanis",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSpray Pharma AB BTA (betald tecknad aktie)",
    "isin": "SE0023312764",
    "transaction_date": "2024-11-29",
    "volume": 2500.0,
    "volume_raw": "2500,0",
    "volume_unit": "Antal",
    "price": 40.0,
    "price_raw": "40,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 100000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-11-28",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Per Andersson",
    "person_in_leading_position": "Per Andersson",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSPRAY BTA",
    "isin": "SE0023312764",
    "transaction_date": "2024-11-28",
    "volume": 750.0,
    "volume_raw": "750,0",
    "volume_unit": "Antal",
    "price": 40.0,
    "price_raw": "40,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 30000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-11-28",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Per Andersson",
    "person_in_leading_position": "Per Andersson",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "XSPRAY TR",
    "isin": "SE0023312756",
    "transaction_date": "2024-11-25",
    "volume": 190310.0,
    "volume_raw": "190310,0",
    "volume_unit": "Antal",
    "price": 0.177,
    "price_raw": "0,177",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 33684.869999999995,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-11-23",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "Xspray TR",
    "isin": "SE0023312756",
    "transaction_date": "2024-11-22",
    "volume": 2100000.0,
    "volume_raw": "2100000,0",
    "volume_unit": "Antal",
    "price": 0.1,
    "price_raw": "0,10",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 210000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-11-21",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "IARU Institutet för Affärsjuridisk Rådgivning i Uppsala AB",
    "person_in_leading_position": "Torbjörn Koivisto",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "XSPRAY TR",
    "isin": "SE0023312756",
    "transaction_date": "2024-11-21",
    "volume": 5000.0,
    "volume_raw": "5000,0",
    "volume_unit": "Antal",
    "price": 0.18,
    "price_raw": "0,18",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 900.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-11-21",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Robert Molander",
    "person_in_leading_position": "Robert Molander",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "XSPRAY TR",
    "isin": "SE0023312756",
    "transaction_date": "2024-11-20",
    "volume": 10000.0,
    "volume_raw": "10000,0",
    "volume_unit": "Antal",
    "price": 0.0112,
    "price_raw": "0,0112",
    "currency": "USD",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 112.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-11-20",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Anders Bladh",
    "person_in_leading_position": "Anders Lennart Bladh",
    "position": "Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "XSPRAY TR",
    "isin": "SE0023312756",
    "transaction_date": "2024-11-20",
    "volume": 13514.0,
    "volume_raw": "13514,0",
    "volume_unit": "Antal",
    "price": 0.14,
    "price_raw": "0,14",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 1891.9600000000003,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-11-19",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Glimberg Consulting AB",
    "person_in_leading_position": "Linda Glimberg",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "BTA (betald tecknad aktie)",
    "instrument_name": "XSPRAY BTA",
    "isin": "SE0023312764",
    "transaction_date": "2024-11-18",
    "volume": 200.0,
    "volume_raw": "200,0",
    "volume_unit": "Antal",
    "price": 40.0,
    "price_raw": "40,0",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 8000.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-11-18",
    "issuer": "XSpray Pharma AB (publ)",
    "lei": "549300NGRQCNZ3X4L157",
    "reporting_person": "Maris Hartmanis",
    "person_in_leading_position": "Maris Hartmanis",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Avyttring",
    "category": "disposal",
    "instrument_type": "Teckningsrätt/Uniträtt",
    "instrument_name": "Xspray Pharma AB Teckningsrätter",
    "isin": "SE0023312756",
    "transaction_date": "2024-11-18",
    "volume": 13159.0,
    "volume_raw": "13159,0",
    "volume_unit": "Antal",
    "price": 0.2002,
    "price_raw": "0,2002",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 2634.4318,
    "status": "Aktuell",
    "is_current_report": true
  }
]